| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |